• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在罕见癌症中实施以患者为中心的临床和研究导航:加拿大胆管癌协作组(C3)

Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3).

作者信息

Attieh Samar, Angka Leonard, Lafontaine Christine, Mitchell Cynthia, Carignan Julie, Ilkow Carolina, Turcotte Simon, Goodwin Rachel, Auer Rebecca C, Loiselle Carmen G

机构信息

Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.

Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

出版信息

Curr Oncol. 2025 Aug 1;32(8):436. doi: 10.3390/curroncol32080436.

DOI:10.3390/curroncol32080436
PMID:40862805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12384775/
Abstract

Person-centered navigation (PCN) in healthcare refers to a proactive collaboration among professionals, researchers, patients, and their families to guide individuals toward timely access to screening, treatment, follow-up, and psychosocial support. PCN-which includes professional, peer, and virtual guidance, is particularly crucial for rare cancers, where affected individuals face uncertainty, limited support, financial strain, and difficulties accessing relevant information, testing, and other services. The Canadian Cholangiocarcinoma Collaborative (C3) prioritizes PCN implementation to address these challenges in the context of Biliary Tract Cancers (BTCs). C3 uses a virtual PCN model and staffs a "C3 Research Navigator" who provides clinical and research navigation such as personalized guidance and support, facilitating access to molecular testing, clinical trials, and case reviews through national multidisciplinary rounds. C3 also supports a national network of BTC experts, a patient research registry, and advocacy activities. C3's implementation strategies include co-design, timely delivery of support, and optimal outcomes across its many initiatives. Future priorities include expanding the C3 network, enhancing user engagement, and further integrating its innovative approach into routine care.

摘要

医疗保健中的以患者为中心的导航(PCN)是指专业人员、研究人员、患者及其家属之间的积极协作,以引导个人及时获得筛查、治疗、随访和心理社会支持。PCN包括专业指导、同伴指导和虚拟指导,对于罕见癌症尤为关键,因为受影响的个体面临不确定性、支持有限、经济压力以及获取相关信息、检测和其他服务的困难。加拿大胆管癌协作组(C3)将实施PCN作为优先事项,以应对胆管癌(BTC)背景下的这些挑战。C3采用虚拟PCN模型,并配备了一名“C3研究导航员”,该导航员提供临床和研究导航,如个性化指导和支持,通过全国多学科会诊促进分子检测、临床试验和病例审查。C3还支持一个全国性的BTC专家网络、一个患者研究登记处和宣传活动。C3的实施策略包括共同设计、及时提供支持以及在其众多举措中实现最佳结果。未来的优先事项包括扩大C3网络、提高用户参与度以及将其创新方法进一步融入常规护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b3/12384775/9fe702f83cce/curroncol-32-00436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b3/12384775/1a8a22b284c5/curroncol-32-00436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b3/12384775/9fe702f83cce/curroncol-32-00436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b3/12384775/1a8a22b284c5/curroncol-32-00436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b3/12384775/9fe702f83cce/curroncol-32-00436-g002.jpg

相似文献

1
Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3).在罕见癌症中实施以患者为中心的临床和研究导航:加拿大胆管癌协作组(C3)
Curr Oncol. 2025 Aug 1;32(8):436. doi: 10.3390/curroncol32080436.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Tuberculosis Prevention, Control, and Elimination结核病的预防、控制与消除
4
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
5
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.肝外胆管癌的管理中的现行标准、多学科方法和未来方向。
Curr Treat Options Oncol. 2024 Jan;25(1):127-160. doi: 10.1007/s11864-023-01153-5. Epub 2024 Jan 5.
6
Rehabilitation access for individuals with cognitive-communication challenges after traumatic brain injury: A co-design study with persons with lived experience.创伤性脑损伤后认知-沟通障碍个体的康复途径:一项与具有亲身体验者共同设计的研究。
Int J Lang Commun Disord. 2024 Mar-Apr;59(2):648-664. doi: 10.1111/1460-6984.12895. Epub 2023 May 15.
7
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panel.肝内胆管癌:多学科专家小组对分子检测、靶向治疗及未来方向的见解
Hepatol Commun. 2025 Jun 9;9(7). doi: 10.1097/HC9.0000000000000743. eCollection 2025 Jul 1.
8
Shaping the future of primary care in Canada: trainee insights on patient and public engagement in health system transformation research.塑造加拿大初级医疗的未来:实习生对患者及公众参与卫生系统转型研究的见解
Health Res Policy Syst. 2025 Aug 4;23(1):98. doi: 10.1186/s12961-025-01366-0.
9
Patient buy-in to social prescribing through link workers as part of person-centred care: a realist evaluation.患者通过联络人员接受社会处方作为以患者为中心的护理的一部分:一项现实主义评价。
Health Soc Care Deliv Res. 2024 Sep 25:1-17. doi: 10.3310/ETND8254.
10
The effectiveness of patient navigation programs for adult cancer patients undergoing treatment: a systematic review.成人癌症患者治疗期间患者导航项目的有效性:一项系统评价
JBI Database System Rev Implement Rep. 2016 Feb;14(2):295-321. doi: 10.11124/jbisrir-2016-2324.

本文引用的文献

1
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System.公共资助医疗体系中分子肿瘤委员会指导下的胆管癌靶向治疗
Curr Oncol. 2025 Jan 31;32(2):80. doi: 10.3390/curroncol32020080.
2
Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics.基于分子特征的胆管癌靶向治疗现状与展望
Cancer Lett. 2025 Apr 1;614:217540. doi: 10.1016/j.canlet.2025.217540. Epub 2025 Feb 7.
3
Adapting, implementing and evaluating a navigation intervention for older people with cancer and their family caregivers in six countries in Europe: the Horizon Europe-funded EU NAVIGATE project.
在欧洲六个国家为老年癌症患者及其家庭护理人员调整、实施和评估一项导航干预措施:由“地平线欧洲”资助的欧盟导航项目。
Palliat Care Soc Pract. 2024 Oct 17;18:26323524241288873. doi: 10.1177/26323524241288873. eCollection 2024.
4
An integrative review on the oncology nurse navigator role in the Canadian context.关于加拿大背景下肿瘤护理导航员角色的综合综述。
Can Oncol Nurs J. 2023 Nov 1;33(4):385-399. doi: 10.5737/23688076334385. eCollection 2023 Fall.
5
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.度伐利尤单抗联合吉西他滨和顺铂治疗晚期胆道癌。
NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1.
6
Molecular tumour boards - current and future considerations for precision oncology.分子肿瘤委员会——精准肿瘤学的当前和未来考量。
Nat Rev Clin Oncol. 2023 Dec;20(12):843-863. doi: 10.1038/s41571-023-00824-4. Epub 2023 Oct 16.
7
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments.胆管癌治疗中的可靶向分子改变:现有治疗方法概述
Cancers (Basel). 2023 Sep 6;15(18):4446. doi: 10.3390/cancers15184446.
8
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature.癌症诊疗全程中的患者导航:系统评价和新兴文献概述。
CA Cancer J Clin. 2023 Nov-Dec;73(6):565-589. doi: 10.3322/caac.21788. Epub 2023 Jun 26.
9
Emerging roles and opportunities for rare disease patient advocacy groups.罕见病患者权益倡导组织的新角色与机遇
Ther Adv Rare Dis. 2023 Apr 24;4:26330040231164425. doi: 10.1177/26330040231164425. eCollection 2023 Jan-Dec.
10
Hope and cancer.希望与癌症。
Curr Opin Psychol. 2023 Feb;49:101506. doi: 10.1016/j.copsyc.2022.101506. Epub 2022 Nov 1.